while most people focus on q1, i think worth reminding everyone that what the mgmt says about q2 and beyond is the KEY. after all, how often do you see companies beat #'s and stock goes down due to cautious tone? in other words, who CARES about qtr!?!
btw, recall that after all the hoopla on everyone guessing the final q4 #s on last earnings, qcor beat q4 handily on both rev and eps - and yet the stock didn't go up afterwards.
why? because of the commentary on q1 for operational transitions. now that we're nearly done with transition, the focus will be on q2/2H.
so here's the main thing to remember:
the items from q1 were mostly one-time and/or supply constraint. the DEMAND side is still strong and acthar continues to help patients who have failed other drugs(or have nothing that helps).
my 2 cents.